Delivery Order SPE2DB22D1202-SPE2DB24FUNR1
Award Date 1/26/24
Potential Completion Date 1/29/24
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,162.25 firm fixed-price delivery order is for 4563554227 - Ropivacaine 0.2% 400 mg/200 ml, a pharmaceutical product used for pain management. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Ropivacaine 0.2% 400 mg/200 ml injections. The contract, valued at $9,396.54, is a firm fixed-price delivery order with an ultimate completion date of October 17, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,988.43 firm fixed-price delivery order is for Ropivacaine 0.2% 400 mg/200 ml injectables, with a completion date of August 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectable medication. The $5,997.77 firm-fixed price delivery order has a completion date of November 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the...
- This federal contract award, valued at $1,982.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4564415866 - Ropivacaine 0.2% 400 mg/200 ml 200 ml, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 29, 2024 and is a Firm Fixed Price Delivery Order. The contract was awarded on April 26, 2024 and is not designated as a set-aside....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,324.51, is for the delivery of 400 mg/200 ml of the medication Ropivacaine 0.2% in 200 ml vials. The contract has an ultimate completion date of January 30, 2025 and is a Firm Fixed Price Delivery Order. This contract is not associated with any set-aside designation. Amerisourcebergen Drug...
- This federal contract award, with ID SPE2DX15D3404|SPE2DX24F0YJF, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $3,773.42 for the supply of 400 mg/200 mL of the pharmaceutical product Ropivacaine 0.2%. The contract has no set-aside designation, indicating open competition. It is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,639.35, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $14,089.80, is for the delivery of 400 mg/200 mL Ropivacaine 0.2% injectable medication. The contract is structured as a Firm Fixed Price Delivery Order with an ultimate completion date of November 16, 2023. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds...
- This federal contract award, identified as SPE2DB22D3016|SPE2DB24FAEC0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,594.70, is for the delivery of Ropivacaine 0.2% 400 mg/200 mL medication. This is a Firm Fixed Price delivery order contract with an ultimate completion date of November 27, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open...